408 related articles for article (PubMed ID: 31614303)
1. Assessment of gut microbiota fecal metabolites by chromatographic targeted approaches.
Fiori J; Turroni S; Candela M; Gotti R
J Pharm Biomed Anal; 2020 Jan; 177():112867. PubMed ID: 31614303
[TBL] [Abstract][Full Text] [Related]
2. Metabolome analysis for investigating host-gut microbiota interactions.
Chen MX; Wang SY; Kuo CH; Tsai IL
J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S10-S22. PubMed ID: 30269936
[TBL] [Abstract][Full Text] [Related]
3. Gastro-intestinal tract: The leading role of mucosal immunity.
Steinert A; Radulovic K; Niess J
Swiss Med Wkly; 2016; 146():w14293. PubMed ID: 27045424
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
Luan H; Wang X; Cai Z
Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
Lavelle A; Sokol H
Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145
[TBL] [Abstract][Full Text] [Related]
6. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
7. Challenges of metabolomics in human gut microbiota research.
Smirnov KS; Maier TV; Walker A; Heinzmann SS; Forcisi S; Martinez I; Walter J; Schmitt-Kopplin P
Int J Med Microbiol; 2016 Aug; 306(5):266-279. PubMed ID: 27012595
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.
Xie G; Zhang S; Zheng X; Jia W
Electrophoresis; 2013 Oct; 34(19):2787-98. PubMed ID: 23775228
[TBL] [Abstract][Full Text] [Related]
9. Aflatoxin B1 Disrupts Gut-Microbial Metabolisms of Short-Chain Fatty Acids, Long-Chain Fatty Acids, and Bile Acids in Male F344 Rats.
Zhou J; Tang L; Wang J; Wang JS
Toxicol Sci; 2018 Aug; 164(2):453-464. PubMed ID: 29897551
[TBL] [Abstract][Full Text] [Related]
10. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
[TBL] [Abstract][Full Text] [Related]
11. Microbiome-Metabolomics Analysis of the Impacts of
Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
[TBL] [Abstract][Full Text] [Related]
12. Sample treatment optimization for fish stool metabolomics.
Hano T; Ito M; Ito K; Uchida M
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():258-267. PubMed ID: 29913338
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
14. Targeted metabolomics for the quantitative measurement of 9 gut microbiota-host co-metabolites in rat serum, urine and feces by liquid chromatography-tandem mass spectrometry.
Zeng Y; Lin Y; Li L; Li Y; Zhang X; Wang M; Chen Y; Luo L; Lu B; Xie Z; Liao Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():133-143. PubMed ID: 30807966
[TBL] [Abstract][Full Text] [Related]
15. Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.
Behr C; Slopianka M; Haake V; Strauss V; Sperber S; Kamp H; Walk T; Beekmann K; Rietjens IMCM; van Ravenzwaay B
Toxicol Appl Pharmacol; 2019 Jan; 363():79-87. PubMed ID: 30502395
[TBL] [Abstract][Full Text] [Related]
16. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
Sittipo P; Shim JW; Lee YK
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
[TBL] [Abstract][Full Text] [Related]
17. Analysis of fecal bile acids and metabolites by high resolution mass spectrometry in farm animals and correlation with microbiota.
Porru E; Scicchitano D; Interino N; Tavella T; Candela M; Roda A; Fiori J
Sci Rep; 2022 Feb; 12(1):2866. PubMed ID: 35190565
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC-MS.
Hsu YL; Chen CC; Lin YT; Wu WK; Chang LC; Lai CH; Wu MS; Kuo CH
J Proteome Res; 2019 May; 18(5):1948-1957. PubMed ID: 30895795
[TBL] [Abstract][Full Text] [Related]
19. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection.
Seekatz AM; Theriot CM; Rao K; Chang YM; Freeman AE; Kao JY; Young VB
Anaerobe; 2018 Oct; 53():64-73. PubMed ID: 29654837
[TBL] [Abstract][Full Text] [Related]
20. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
Zhu T; Goodarzi MO
Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
